Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Back to alerts
BSEKIMIA BIOSCIENCES LIMITEDHighNeutral
Announced Tue, 29 Sept, 2026 · 23:26 IST

Board changes approved at 33rd AGM, independent directors appointed

Management Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.9%Reaction day
₹31.98
prior close
₹32.81
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-1.7% vs market
Pharmaceuticals peers, median of 172sector-0.9%-1.0% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
-0.3
15m
-0.3
30m
-0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.9-0.3-1.7-0.9-1.0
Next day
-3.1-1.5-1.5-1.6-1.4
2d
+0.1-1.5+1.6-2.6+2.7
3d
+3.2-0.2+3.4-1.5+4.7
4d
+4.6-0.5+5.1-1.8+6.4
5d
+6.6-3.2+9.9-3.5+10.1
1w
+7.8-2.2+10.0-4.4+12.2
15d
-6.2-9.5+3.2-9.2+2.9
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

At the 33rd AGM on 28 September 2026, members approved board changes for Kimia Biosciences. Sameer Goel, founder and 74.94 percent shareholder, was re-appointed as Director liable to retire by rotation. Amulya Kumar Nayak was appointed as Director. Ms. Reema Goyal and Mr. Avinash Prabhat were appointed as Independent Non-Executive Directors for 5 years from 4 April 2026 to 3 April 2031. None are debarred by SEBI.

Likely market impact

Routine board refresh. Two new independent directors strengthen oversight. No resignations or governance flags. Founder Sameer Goel retained with 74.94% stake.